$1.11 EPS Expected for Agilent Technologies, Inc. (NYSE:A) This Quarter

Equities analysts expect that Agilent Technologies, Inc. (NYSE:AGet Rating) will post $1.11 earnings per share for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Agilent Technologies’ earnings, with the lowest EPS estimate coming in at $1.11 and the highest estimate coming in at $1.12. Agilent Technologies posted earnings per share of $0.97 in the same quarter last year, which suggests a positive year over year growth rate of 14.4%. The company is expected to issue its next quarterly earnings results after the market closes on Monday, January 1st.

According to Zacks, analysts expect that Agilent Technologies will report full-year earnings of $4.86 per share for the current fiscal year, with EPS estimates ranging from $4.82 to $4.88. For the next fiscal year, analysts anticipate that the business will post earnings of $5.34 per share, with EPS estimates ranging from $5.20 to $5.51. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that follow Agilent Technologies.

Agilent Technologies (NYSE:AGet Rating) last announced its quarterly earnings data on Tuesday, February 22nd. The medical research company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.04. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.66 billion. Agilent Technologies had a return on equity of 27.04% and a net margin of 18.70%. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.06 EPS.

Several equities analysts have weighed in on A shares. SVB Leerink dropped their target price on Agilent Technologies from $175.00 to $145.00 and set an “outperform” rating for the company in a research report on Wednesday, February 23rd. StockNews.com downgraded Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Wednesday, April 27th. Citigroup decreased their price objective on shares of Agilent Technologies from $190.00 to $175.00 and set a “buy” rating for the company in a research note on Wednesday, February 23rd. Robert W. Baird cut their price target on Agilent Technologies from $170.00 to $161.00 in a research report on Wednesday, February 23rd. Finally, Bank of America decreased their price objective on Agilent Technologies from $179.00 to $160.00 and set a “buy” rating for the company in a report on Wednesday, February 23rd. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $158.23.

In other Agilent Technologies news, SVP Michael Tang sold 1,210 shares of Agilent Technologies stock in a transaction that occurred on Friday, March 18th. The stock was sold at an average price of $136.21, for a total value of $164,814.10. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Institutional investors have recently added to or reduced their stakes in the business. Ironwood Wealth Management LLC. grew its position in Agilent Technologies by 142.5% during the second quarter. Ironwood Wealth Management LLC. now owns 485 shares of the medical research company’s stock worth $72,000 after buying an additional 285 shares during the period. Morgan Stanley grew its holdings in shares of Agilent Technologies by 2.9% in the 2nd quarter. Morgan Stanley now owns 1,154,775 shares of the medical research company’s stock worth $170,688,000 after acquiring an additional 33,059 shares during the period. Barclays PLC increased its stake in Agilent Technologies by 18.7% in the 3rd quarter. Barclays PLC now owns 614,314 shares of the medical research company’s stock valued at $96,776,000 after purchasing an additional 96,921 shares in the last quarter. Advisory Alpha LLC raised its holdings in Agilent Technologies by 23.4% during the third quarter. Advisory Alpha LLC now owns 1,910 shares of the medical research company’s stock worth $301,000 after purchasing an additional 362 shares during the last quarter. Finally, Sawtooth Solutions LLC boosted its position in Agilent Technologies by 8.7% during the third quarter. Sawtooth Solutions LLC now owns 1,692 shares of the medical research company’s stock worth $267,000 after purchasing an additional 135 shares in the last quarter.

Shares of Agilent Technologies stock opened at $113.99 on Thursday. The firm has a market capitalization of $34.24 billion, a price-to-earnings ratio of 28.93, a PEG ratio of 2.77 and a beta of 1.06. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.64 and a current ratio of 2.19. Agilent Technologies has a fifty-two week low of $112.64 and a fifty-two week high of $179.57. The stock has a 50 day moving average of $128.94 and a 200 day moving average of $141.60.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 27th. Shareholders of record on Tuesday, April 5th were given a dividend of $0.21 per share. The ex-dividend date was Monday, April 4th. This represents a $0.84 dividend on an annualized basis and a yield of 0.74%. Agilent Technologies’s payout ratio is currently 21.32%.

Agilent Technologies Company Profile (Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Featured Articles

Get a free copy of the Zacks research report on Agilent Technologies (A)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.